Literature DB >> 17565125

Old ways, new means: tobacco industry funding of academic and private sector scientists since the Master Settlement Agreement.

Suzaynn F Schick1, Stanton A Glantz.   

Abstract

When, as a condition of the Master Settlement Agreement (MSA) in 1998, US tobacco companies disbanded the Council for Tobacco Research and the Center for Indoor Air Research, they lost a vital connection to scientists in academia and the private sector. The aim of this paper was to investigate two new research projects funded by US tobacco companies by analysis of internal tobacco industry documents now available at the University of California San Francisco (San Francisco, California, USA) Legacy tobacco documents library, other websites and the open scientific literature. Since the MSA, individual US tobacco companies have replaced their industry-wide collaborative granting organisations with new, individual research programmes. Philip Morris has funded a directed research project through the non-profit Life Sciences Research Office, and British American Tobacco and its US subsidiary Brown and Williamson have funded the non-profit Institute for Science and Health. Both of these organisations have downplayed or concealed their true level of involvement with the tobacco industry. Both organisations have key members with significant and long-standing financial relationships with the tobacco industry. Regulatory officials and policy makers need to be aware that the studies these groups publish may not be as independent as they seem.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565125      PMCID: PMC2598497          DOI: 10.1136/tc.2006.017186

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  26 in total

1.  Institutional addiction to tobacco.

Authors:  J E Cohen; M J Ashley; R Ferrence; J M Brewster; A O Goldstein
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  WHO says tobacco industry "used" institute to undermine its policies.

Authors:  R MacDonald
Journal:  BMJ       Date:  2001-03-10

3.  The ethics of the cash register: taking tobacco research dollars.

Authors:  S Chapman; S Shatenstein
Journal:  Tob Control       Date:  2001-03       Impact factor: 7.552

4.  Turning science into junk: the tobacco industry and passive smoking.

Authors:  J M Samet; T A Burke
Journal:  Am J Public Health       Date:  2001-11       Impact factor: 9.308

5.  Tobacco industry documents: treasure trove or quagmire?

Authors:  R E Malone; E D Balbach
Journal:  Tob Control       Date:  2000-09       Impact factor: 7.552

6.  Tobacco industry efforts subverting International Agency for Research on Cancer's second-hand smoke study.

Authors:  E K Ong; S A Glantz
Journal:  Lancet       Date:  2000-04-08       Impact factor: 79.321

7.  Use of precision-cut tissue slices in organ culture to study metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by hamster lung, liver and kidney.

Authors:  E Richter; S Friesenegger; J Engl; A R Tricker
Journal:  Toxicology       Date:  2000-04-03       Impact factor: 4.221

8.  Philip Morris' new scientific initiative: an analysis.

Authors:  N Hirschhorn; S A Bialous; S Shatenstein
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

9.  The effect of a 2-h exposure to cigarette smoke on the metabolic activation of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice.

Authors:  B G Brown; E Richter; A R Tricker; P H Ayres; D J Doolittle
Journal:  Chem Biol Interact       Date:  2001-11-28       Impact factor: 5.192

10.  Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung and effect of cigarette smoke exposure on in vivo metabolism to biological reactive intermediates.

Authors:  A R Tricker; B G Brown; D J Doolittle; E Richter
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

View more
  13 in total

Review 1.  The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review.

Authors:  Alice Fabbri; Alexandra Lai; Quinn Grundy; Lisa Anne Bero
Journal:  Am J Public Health       Date:  2018-09-25       Impact factor: 9.308

2.  The tobacco industry, researchers, and ethical access to UK Biobank: using the public interest and public good.

Authors:  Benjamin James Capps; Yvette van der Eijk
Journal:  Am J Public Health       Date:  2014-08-14       Impact factor: 9.308

3.  'To prove this is the industry's best hope': big tobacco's support of research on the genetics of nicotine addiction.

Authors:  Kenneth R Gundle; Molly J Dingel; Barbara A Koenig
Journal:  Addiction       Date:  2010-06       Impact factor: 6.526

4.  The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food?

Authors:  Kelly D Brownell; Kenneth E Warner
Journal:  Milbank Q       Date:  2009-03       Impact factor: 4.911

5.  Tobacco papers and tobacco industry ties in regulatory toxicology and pharmacology.

Authors:  Clayton Velicer; Gideon St Helen; Stanton A Glantz
Journal:  J Public Health Policy       Date:  2017-11-07       Impact factor: 2.222

6.  Criteria for evaluating tobacco control research funding programs and their application to models that include financial support from the tobacco industry.

Authors:  J E Cohen; M Zeller; T Eissenberg; M Parascandola; R O'Keefe; L Planinac; S Leischow
Journal:  Tob Control       Date:  2009-02-24       Impact factor: 7.552

7.  Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.

Authors:  Crystal E Tan; Thomas Kyriss; Stanton A Glantz
Journal:  PLoS Med       Date:  2013-05-28       Impact factor: 11.069

8.  "A good personal scientific relationship": Philip Morris scientists and the Chulabhorn Research Institute, Bangkok.

Authors:  Ross Mackenzie; Jeff Collin
Journal:  PLoS Med       Date:  2008-12-23       Impact factor: 11.069

9.  Scientific integrity: critical issues in environmental health research.

Authors:  Domenico Franco Merlo; Kirsi Vahakangas; Lisbeth E Knudsen
Journal:  Environ Health       Date:  2008-06-05       Impact factor: 5.984

10.  Interfield dysbalances in research input and output benchmarking: visualisation by density equalizing procedures.

Authors:  Beatrix Groneberg-Kloft; Carolin Kreiter; Tobias Welte; Axel Fischer; David Quarcoo; Cristian Scutaru
Journal:  Int J Health Geogr       Date:  2008-08-25       Impact factor: 3.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.